(Q51674929)

9 April 2018

title

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. (English)

1 reference

9 April 2018

author

Angelica Sonzogni

3

1 reference

9 April 2018

Patrick Maisonneuve

5

1 reference

9 April 2018

Giuseppe Viale

10

object named as

Giuseppe Viale

1 reference

9 April 2018

author name string

Giuseppe Pelosi

1

1 reference

9 April 2018

Felice Pasini

2

1 reference

9 April 2018

Fausto Maffini

4

1 reference

9 April 2018

Antonio Iannucci

6

1 reference

9 April 2018

Alberto Terzi

7

1 reference

9 April 2018

Giovanni De Manzoni

8

1 reference

9 April 2018

Enrica Bresaola

9

1 reference

9 April 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

9 April 2018

number of pages

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

9 April 2018

volume

97

1 reference

9 April 2018

page(s)

2487-2497

1 reference

9 April 2018

issue

10

1 reference

9 April 2018

Specificity controls for immunocytochemical methods

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

Pulmonary atypical carcinoid: Predictors of survival in 106 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Amphicrine differentiation in bronchioloalveolar cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neural cell adhesion molecule and prognosis of surgically resected lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Chromogranin A gene expression in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Diversity of gene expression in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Tumor extension and cell proliferation in adenocarcinomas of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

p21WAF1/CIP1 expression in primary lung adenocarcinomas: heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Pulmonary preinvasive neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Molecular pathogenesis of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Relationship between vascularity, age and survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Reproducibility of neuroendocrine lung tumor classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Ki-67 immunostaining and survival in operable lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

An achaete-scute homologue essential for neuroendocrine differentiation in the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Chromogranins or chromogranin-like proteins are present in lamellar bodies and pulmonary surfactant of rat alveolar type II cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11376

7 January 2021

Identifiers

DOI

10.1002/CNCR.11376

1 reference

9 April 2018

PubMed ID

12733148

1 reference

9 April 2018